In this episode of LATAM MedTech Insights, we demystify the mandatory INMETRO certification for electro-medical devices in Brazil. We break down the critical requirements of Ordinance 384/2020, a regulation that serves as a vital gatekeeper to one of Latin America's most significant markets. We'll guide you through the conformity assessment process, from selecting a Certification Body to undergoing factory audits and product testing. We explore the distinct roles of ANVISA and INMETRO, clarifying how they work together and what manufacturers must do to satisfy both. We highlight common pitfalls, such as assuming your existing FDA or CE mark documentation is sufficient, and provide actionable insights to ensure a smoother path to certification. This episode is essential listening for any MedTech company planning to sell electro-medical devices in Brazil. A real-world example. A promising European MedTech scale-up developed an innovative portable ultrasound device. They secured CE marking and assumed their technical file was robust enough for global markets. Upon targeting Brazil, they were blocked for months. Their challenge was not the quality of their device, but their failure to understand the nuances of INMETRO's audit process under Ordinance 384/2020, which required specific traceability protocols not emphasized in their EU audit. This oversight led to costly delays and a scramble for local regulatory expertise. Key Takeaways This Episode: 1. What is the fundamental difference between ANVISA's market registration and INMETRO's conformity assessment? 2. How do you select the right INMETRO-accredited Certification Body for your device? 3. What are the three most common documentation mistakes that lead to delays in the certification process? 4. What can you expect during the mandatory on-site factory audit, regardless of your global location? 5. Are INMETRO certificates truly valid indefinitely, and what is the catch? 6. Why is the INMETRO Conformity Identification Seal more than just a label? 7. How can you leverage your Brazil registration strategy for other markets in Latin America? At Pure Global, we transform these complex regulatory hurdles into clear pathways for market access. Our team of local experts, powered by advanced AI and data tools, offers end-to-end solutions for MedTech and IVD companies. From initial regulatory strategy and technical dossier submission to acting as your local representative, we streamline your entry into over 30 global markets, including Brazil. Don't let regulatory complexities be a barrier to your growth. Contact us at [email protected] or visit https://pureglobal.com/ to learn how we can accelerate your global expansion.